What follow-up should you expect from an online HRT provider?

Follow-up after you start HRT should do more than tell you a refill is due. It should check how treatment is fitting into your life, catch what has improved and what hasn't, and give you a clear way to raise a problem before the next scheduled conversation.

Ninety days of medication followed by ninety days of wondering whether you're using it right, or whether it's working, is not follow-up. It's a shipment.

Reviewer: Nathan Parker, PharmD.

How often should HRT be reviewed?

Menopause guidance gives a useful reference point. NICE recommends reviewing treatment at 3 months to see how well it's working and how you're tolerating it, then once a year, with an earlier review whenever treatment isn't helping or side effects get in the way. ACOG similarly advises talking with your clinician every year about whether to continue.

Treat that schedule as a reference for planned reviews, not a limit on when you can ask for help. An annual review is never a reason to sit on a problem for a year.

MintRx's new Female HRT/TRT program is built around more contact than that. It starts with a pharmacist conversation about how you're actually doing and what you want to be different. After at-home program labs, a pharmacist walks through the results with you in the context of your symptoms and history. From there, the program is built around monthly pharmacist check-ins, and before each 90-day fill the plan includes repeat program labs and another treatment review with your prescriber.

Those program labs are part of how this program tracks your care. They are not a claim that every woman needs a lab panel to identify menopause, and they don't replace the most important information: how you feel.

What should a follow-up conversation cover?

A good follow-up starts with you, not the prescription. You shouldn't have to tell your story from the beginning every time. Expect questions like:

• How are you actually using it? Where you apply it, what time of day, and whether showering, swimming or a busy morning gets in the way.
• What has changed, and what is still bothering you most?
• How are you sleeping, and do you wake up rested?
• How are your mood and stress?
• How is this affecting home, work and the things you enjoy?
• Are you closer to what you said you wanted when you started?

That last question matters most. If your goal was sleeping through the night or having energy left after work, that is what the follow-up should measure, not just whether a number moved.

What can come out of a follow-up?

Not every follow-up should end in a change. Sometimes the right answer is to keep the plan steady and give it time, with a clear reason why. Other times it's practical: a different application time, help with technique, or sorting out a supplement that overlaps with your treatment.

Sometimes one symptom improves while another doesn't. If hot flashes are better but vaginal discomfort is still affecting you, that deserves its own conversation and possibly a targeted treatment, not an automatic increase in the same medication. The guide on how local and systemic HRT options compare explains why those are different jobs.

And sometimes a symptom points somewhere else. Fatigue, poor sleep and low mood don't all have one cause, and more hormone is not the answer to every one of them.

Your pharmacist doesn't change your prescription. When the plan needs reconsidering, the pharmacist takes the question to your prescriber, and the next step should be clear to you even when a decision is still pending.

When shouldn't you wait for the next check-in?

Reach out between scheduled conversations if side effects are bothering you, treatment is hard to use, symptoms are getting worse, or you start a new medicine or get a new diagnosis. You don't need to wait for the next check-in or the next round of labs to ask for a review.

Bleeding needs particular attention. Some spotting can happen in the first months of systemic HRT or after a dose change, and your team should ask about it. Bleeding you weren't expecting, or bleeding beyond those early months, needs prompt medical evaluation rather than an assumption that it's the hormones.

Chest pain, sudden shortness of breath or signs of a stroke need emergency care. Call 911. A portal message or pharmacist appointment is not the place for an emergency.

A refill is not a review

A payment, a subscription renewal or a box on your doorstep tells you an order went through. It doesn't tell you anyone looked at how treatment is going. A renewed prescription, a change in your health history or a provider review may add steps before a refill ships, and that's appropriate.

Ask any online HRT provider how the two connect: who reviews your treatment before another prescription, how often, and what happens if your prescriber needs more information. For the general flow from provider review to delivery to ongoing support, read what happens after you start treatment online. If you're unsure whether a question belongs with the pharmacist, the prescriber or Client Care, the guide on when to call the pharmacy team sorts that out.

What to ask before you start with any provider

• Who will I talk to after the medication ships, and how often?
• Will that person remember what I said I wanted help with?
• How do I raise a side effect or a question between scheduled visits?
• Who decides whether to change my treatment, and how will I hear about it?
• Which tests are part of the plan, what is each one meant to answer, and who explains the results?
• What is included in the cost, and what is separate?

If your plan includes a compounded preparation, follow-up is also where you ask why that formulation fits you and what you'll look at to decide whether it's helping. Compounded medications are not FDA-approved, so the reason for choosing one should be specific to you.

If you're still deciding whether to start, read whether you can get online HRT for menopause symptoms, or see the hormone therapy options MintRx currently lists.

FAQ

The question worth asking first

Before you start, ask: who will I talk to after this arrives, and how often? The answer tells you whether you're signing up for a prescription or for care.

If you have questions about a hormone plan you're on now, or want to understand what follow-up should look like for you, talk with a MintRx pharmacist. You deserve someone in your corner, not just a box in your mailbox.

Sources

• NICE NG23: Menopause, identification and management
• ACOG: Hormone Therapy for Menopause
• ACOG: Perimenopausal Bleeding and Bleeding After Menopause
• FDA: Compounding and the FDA, Questions and Answers

NICE is UK clinical guidance, not a US prescribing rule. Your US clinician determines the review schedule appropriate for you.